European Directorate for the Quality of Medicines & HealthCare

The procedure for the Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) is an important tool for both regulators and industry. Since its establishment in 1994, it has enhanced the efficiency of the authorisation process for medicines containing substances covered by European Pharmacopoeia monographs. Today, the CEP procedure plays a vital role in protecting public health, ensuring regulatory efficiency and promoting global harmonisation and helps to build and maintain trust in the pharmaceutical field around the world. Join us at the international conference “Certified for success: using the CEP Procedure to elevate quality and drive trust” to take a deep dive into the latest developments in this fast-moving regulatory environment and explore what the future holds for the CEP procedure.

Don't miss out – places are limited! Reserve your spot today!

• Navigating CEP 2.0: a game changer
  Discover how the EDQM addressed the challenges to deliver an updated CEP that meets our stakeholders’ needs and provides greater transparency.
• Get ready! New developments on the horizon
  Stay ahead with insights into recent and upcoming changes, policy updates, and future scientific expectations.
• The power of GMP inspections
  Learn about the impact, evolution and future plans for the Inspection Programme.
• Maximising the potential of CEPs
  Explore the added value of CEPs through real-world success stories and understand the benefits of adopting good reliance practices to improve regulatory efficiency.
• Panel discussion on ‘Future place of Certification in the European Regulatory Landscape’
  Engage in a multi-stakeholder discussion on emerging topics such as artificial intelligence and the place of the CEP procedure in light of the upcoming legislative changes at EU level.

Presentations will be followed by panel discussions and Q&A sessions, providing ample opportunity for interaction and networking.

Download the preliminary programme (subject to change)

This conference would be of great interest to professionals from the pharmaceutical or chemical industry, regulatory agencies and academic institutions.

The registration fees per delegate are:

• Industry/Private sector: 700 Euros
• Non-industry/Academia/Public sector:  500 Euros
• CEP experts/OGYÉI participants only: 250 Euros

This fee includes all the documentation and lunch, refreshments and a social gathering on Tuesday evening, 23 September. It does not include accommodation and travel expenses.

This conference is an IN-PERSON ONLY event.

REGISTER HERE